The company will file the NDA for BRIMOCHOL™ PF, a once-a-day eye drop for the treatment of presbyopia, with a…
Read More
The company will file the NDA for BRIMOCHOL™ PF, a once-a-day eye drop for the treatment of presbyopia, with a…
Read MoreBlueprint’s most recently approved drug is Ayvakit, which the US Food and Drug Administration approved in 2020 to treat gastrointestinal…
Read More